Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Has announcements × Tumor-Agnostic × Clear all

Phase

Phase 3 2 Phase 1/2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 40 Genitourinary 32 Other hematologic neoplasm 31 Lymphoid 31 Gastrointestinal 29 Breast 28 Gynecologic 16 Plasma cell 14 Classical hematology 11 Dermatologic 10 Myeloid 7 Endocrine 5 Head & Neck 4 Sarcoma 3 Tumor-Agnostic 2 NET 2 CNS 2 Other solid neoplasm 1

Conditions

Neoplasm Metastasis 1 Carcinoma 1

Interventions

margetuximab 1 atezolizumab 1 Trastuzumab 1 Pemetrexed 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02492711 2025-03-17

SOPHIA

MacroGenics

Phase 3 Completed

624 enrolled 17 charts 2 FDA

Neoplasm Metastasis

NCT02367781 2021-08-09

IMpower130

Hoffmann-La Roche

Phase 3 Completed

723 enrolled 28 charts 1 FDA

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡